MacroGenics (MGNX) PT Lowered to $20 at Stifel
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Price: $4.09 --0%
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Rating Summary:
13 Buy, 9 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 8 | New: 13
Join SI Premium – FREE
Stifel analyst Stephen Willey lowered the price target on MacroGenics (NASDAQ: MGNX) to $20.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $55 at Guggenheim
- Invesco Mortgage Capital (IVR) PT Lowered to $7.75 at UBS
- Medartis Holding AG (MED:SW) PT Raised to CHF105 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
